Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions
Clinical trial NCT02421679 · COMPLETED
Trial details
- NCT number
- NCT02421679
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-14
- Primary completion
- 2016-05-26
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.